Pro-Active Moves for Growth Auxly Cannabis

Auxly is creating a world-class platform by forming partnerships with best-in-class cultivators, product innovators, and developers, researchers, and marketers. The company provides its partners with ongoing cornerstone support in cultivation, regulatory, construction, retail, branding and financing to help them realize their full potential. Auxly directly and indirectly through its investment in ICC International Cannabis (CSE: WRLD) has a presence or access to 22 countries.

The company’s stock has unsurprisingly found enormous strength in the recent past. It has been powering due to the favorable impact of the company’s positive announcements about the development of its assets and partners along with the growing popularity of the industry. All the above have positioned the company for the future as it continues to execute on its vertically integrated strategy.

Auxly continues to build out its platform at an industry-leading pace and make progress on the development of its assets and partners at all touch points of the cannabis value chain. The management continues to make several strategic additions to the overall platform in line with the company’s domestic and international expansion plans. Analyst tracking the stock are extremely bullish about the steady progress Auxly have made in the recent past as the Company works towards achieving its long -term strategic goals.

Recent announcements:

  • On Jan 24th, the company announced that it had signed a definitive agreement with 2368523 Ontario Limited (d/b/a) Curative Cannabis (“Curative“). The Company will acquire 46% of the common shares of Curative and enter into a long-term cannabis purchase and sale agreement to fund the construction and development costs of Curative’s cannabis cultivation facility in Chatham-Kent, Ontario.
  • On Jan 9th, the company announced that further to its previous releases, it had completed the acquisition of 80% of the outstanding common shares of Inverell S.A. The Transaction positions the Company as a leader in the global CBD economy with a highly efficient, low-cost source of cannabinoids for international distribution, including through the Company’s strategic partnership with ICC International Cannabis Corporation Inc. (CSE: WRLD) which provides the Company with access to 16 markets through a network of 35,000 pharmacies. Importantly, the low cost, high purity CBD produced by Inverell gives the Company a long-term and stable supply of CBD to support the research, development, and manufacturing of cannabis-derived products at Dosecann Inc., the Company’s wholly-owned Licensed Processor facility located in Prince Edward Island, Canada.


Key Financial and Operational milestones in 2018

  • Positioned Auxly as a vertically integrated cannabis company with wholly-owned assets at each segment of the value chain
  • 5 wholly-owned subsidiaries and 13 streaming partners**
  • Auxly strategically organized into three segments of the industry value-chain: Upstream, Midstream, and Downstream
  • A significant working capital balance of $303M, inclusive of a $115M bought deal financing led by BMO Capital Markets
  • A fully Funded capacity of 160,000kg per annum by 2021
  • Expanded Internationally with the acquisition of Inverell S.A.

** The Inverell acquisition remains subject to final regulatory approvals in Uruguay

Analyst Views: Analyst tracking the stock and the industry believes that the Auxly platform is about more than just deploying capital, as the company is diversifying its streaming deals and have developed the ancillary tools and infrastructure to make those streams successful. Consequently, the company’ is well positioned to capture high-margin segments of the market through extracted products, infused functional foods and Natural Health Products. Considering all this, the company is in an extremely favorable risk-reward position, and value investors should consider exposure in this sector as the backdrop remains exceptionally favorable.

About the company: Auxly is a vertically integrated cannabis company with diverse operations across Canada and Uruguay. The company was formed with the primary intent of providing financing solutions to cannabis license applicants and has evolved into a platform spanning the entire cannabis value chain. Auxly’s management believes that a vertically integrated model, adapted for the cannabis space, allows for substantive control over its operations through increased operational flexibility, economic resiliency, and improved product margin dynamics in an effort to create long term shareholder value. Auxly currently operates three distinct, yet synergistic, segments:

  • Upstream – Auxly’s diverse cannabis cultivation platform across its streaming partners, joint ventures and wholly-owned subsidiaries;
  • Midstream – Auxly’s processing and development platform focused on the development of proprietary cannabis-derived products and related intellectual property to address consumer needs through its wholly-owned subsidiary, Dosecann; and
  • Downstream – Auxly’s medical, recreational and international distribution platform.

Cannabis Industry Overview: The legalization of an existing market is predicted to reap enormous benefits.

  • CIBC World Markets believes that the cannabis market will reach $6.8 billion by 2020, outpacing the spirits industry
  • The overall industry is projected to generate $1 billion in EBITDA in 2020 with manufacturing companies accounting for over 85% of it and retailers accounting for the remaining 15%
  • Active M&A market as companies look to create vertical integration partnerships similar to Auxly + Dosecann
  • Similar to the alcoholic beverages industry, brand loyalty and repeat customers will be crucial in obtaining market share

Projected Stabilized Values By 2024 ($ Billions in Revenue)

Third Quarter 2018 Financial Results

Commentary on the recent financial release: The further progress highlighted the third quarter of 2018, Auxly has made in developing its assets and securing new accretive relationships across all of its business channels. The company is increasingly differentiating itself through its focus on science-driven product innovation at Dosecann. Auxly have assembled a world-class team and have continued to invest in the infrastructure and strategic initiatives that it feels will best position Dosecann to be a leading player in the product development and a manufacturing segment of the cannabis market

Robust Liquidity and financial flexibility: The Company maintained a strong balance sheet and liquidity position with $236,920,000 in cash and cash equivalents at the end of the third quarter earmarked for funding Auxly’s streaming partners, wholly-owned subsidiaries, downstream distribution efforts and general and administration costs. The increase in the cash and working capital balances are attributable primarily to the Company raising $215,115,000 in debt and equity financings year to date in addition to raising $95,017,000 in warrant and broker warrant unit exercises. During the nine months ended September 30th, 2018, cash used in investing activities totaled $75,307,000 which includes strategic investments made in subsidiaries, streaming partners and strategic partners.

 Key risk factors and potential stock drivers:

  • Licensing Risk – While the number of LPs continues to climb, sales approval remains a significant constraint to supplying the market. Despite Health Canada’s “expedited licensing,” it is estimated that Health Canada has approved less than 4% of all licensed producer applications. Regulatory uncertainty is obstructing some LPs ability to make definitive expansion plans
  • Scaling Problems – Cannabis is a difficult plant to grow at scale while meeting Health Canada quality standards, and no LP has yet demonstrated the ability to cultivate cannabis on a large scale
  • Auxly is on the verge of seeing stable and meaningful results from their current investments. Analysts remain hopeful that these payoffs will take shape quite soon and remain bullish about the stock price.
  • Auxly is still an early stage company and will likely operate at a loss as it grows its market position and seeks ways to monetize it.  Therefore, its ability to maintain liquidity and financial flexibility to fund its incremental capital requirements will remain a challenge for the company.
  • Notwithstanding recent positive developments, Marijuana remains illegal under federal law. It is a Schedule I controlled substance. Even in those jurisdictions in which the use of medical marijuana has been legalized at the state level, its prescription is a violation of federal law.

Stock Performance


  • On Friday, February 2nd, 2019, CBWTF closed at $0.7145, on an above average volume of 1.07M shares exchanging hands. Market capitalization is $428.383 million. The current RSI is 56.86
  • In the past 52 weeks, shares of CBWTF have traded as low as $0.4440 and as high as $1.60
  • At $0.7145, shares of CBWTF are trading above its 50-day moving average (MA) at $0.64 and below its 200-day moving average (MA) at $0.83
  • The present support and resistance levels for the stock are at $0.6810 & $0.7608 respectively. 


About Traders News Source

Over 75% in realistic bookable gains so far in 2019

Any trader in any market would fall all over themselves to book gains like this. So, if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in class. We know with a large following comes a large responsibility as we have everyone from the institutional investor to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

View our track record, currently featured reports and updates here-

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Traders” to the phone number 25827 from your cell phone.

Pay attention, if you’re just joining us you are about to see why everyone wants to be like us.

The Traders News Team



Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.

Traders News Source has not been compensated for this report by anyone and the opinions if any are that of the author Vikas Agrawal, CFA. Author’s Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I, wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in the article.

This web site, published by TNS LLC, and is an investment newsletter that is built on the premise of assisting individual investors in learning about investing. Our goal as publishers of financial information is to provide research and analysis of investments to our subscribers. TNS LLC does not give buy or sell recommendations. We do purchase distribution rights from analyst, financial writers and bloggers for a fee that may be licensed to issue price targets and recommendations. Furthermore, we encourage you to speak to a licensed professional prior to making an investment in any type of publicly traded security.

We do sell advertising to other companies including brokerage firms, web sites, publicly traded issuers, investor relations firms, and investment publications, among others. TNS LLC makes no warranty as to the policies of these organizations, and in no way endorses their offers, services, or the content of their advertisements.

When an advertiser is a publicly traded company or a third party acting on behalf of a public company, we fully disclose all compensation in the email advertisement. Such disclosure is included in a disclosure statement in each of the advertisements sent via email.

17B Disclosure

Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.

PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.

TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur.

Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.